Electra Therapeutics, Inc. releases quarterly results, showcasing financial updates and strategic directions in the biological products sector.
| Name | Electra Therapeutics, Inc. |
|---|---|
| CIK | 0002088082 |
| Tickers | ETRA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 832193635 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (888) 743-2290 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Electra Therapeutics, Inc. releases quarterly results, showcasing financial updates and strategic directions in the biological products sector.
Electra Therapeutics has reported significant stock transactions by major stakeholders, signaling strategic moves within the company and the biological products industry.
Electra Therapeutics announces significant stock transactions by director Carl L. Gordon, reflecting ongoing investment activities in the biological products sector.
Westlake BioPartners invests in Electra Therapeutics, acquiring a 10.1% stake, signaling confidence in the company's growth in the biological products sector.
41 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-005295 | 005-95943 | 261559149 | 34 | 10654 | |||
| 2026-11-12 | 10-Q | 10-Q | 0001193125-26-458476 | 001-43477 | 261547292 | 34 | 11925931 | 1 | 1 | |
| 2026-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-458464 | 001-43477 | 261547240 | 34 | 368384 | 1 | 1 |
| 2026-11-10 | 4 | xslF345X06/ownership.xml | 0000947871-26-001011 | 15465 | ||||||
| 2026-11-10 | 4 | xslF345X06/ownership.xml | 0000947871-26-001010 | 19373 | ||||||
| 2026-11-05 | 4 | xslF345X06/ownership.xml | 0000947871-26-000986 | 22215 | ||||||
| 2026-11-05 | 4 | xslF345X06/ownership.xml | 0000947871-26-000985 | 26123 | ||||||
| 2026-10-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-120294 | 005-95943 | 261503155 | 34 | 58469 | |||
| 2026-09-28 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-111478 | 005-95943 | 261418857 | 34 | 18130 | |||
| 2026-09-28 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-405752 | 005-95943 | 261418850 | 34 | 134891 | |||
| 2026-09-25 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0000947871-26-000898 | 005-95943 | 261411207 | 34 | 35322 | |||
| 2026-09-23 | 4 | xslF345X06/ownership.xml | 0000947871-26-000881 | 25529 | ||||||
| 2026-09-23 | 4 | xslF345X06/ownership.xml | 0000947871-26-000880 | 29437 | ||||||
| 2026-09-21 | 3 | OWNERSHIP DOCUMENT | 0001104659-26-109399 | 11860 | ||||||
| 2026-09-21 | 4 | xslF345X06/form4-09212026_100905.xml | 0002153365-26-000004 | 7283 | ||||||
| 2026-09-21 | 4 | xslF345X06/form4-09212026_100957.xml | 0001817449-26-000009 | 7292 | ||||||
| 2026-09-21 | 4 | xslF345X06/form4-09212026_100928.xml | 0002153366-26-000006 | 7656 | ||||||
| 2026-09-21 | 4 | xslF345X06/form4-09212026_100932.xml | 0002153364-26-000004 | 7675 | ||||||
| 2026-09-21 | S-8 | S-8 | 0001193125-26-396741 | 333-299059 | 261394433 | 33 | 247606 | 1 | 1 | |
| 2026-09-21 | 8-K | 8-K | 5.03,8.01,9.01 | 0001193125-26-396646 | 001-43477 | 261393832 | 34 | 186872 | 1 | 1 |
| 2026-09-18 | 424B4 | 424B4 | 0001193125-26-395670 | 333-298617 | 261391561 | 33 | 6967800 | |||
| 2026-09-18 | 3 | xslF345X06/ownership.xml | 0000947871-26-000874 | 14519 | ||||||
| 2026-09-18 | 3 | xslF345X06/form3-09182026_080937.xml | 0002153761-26-000002 | 11180 | ||||||
| 2026-09-18 | 3 | xslF345X06/form3-09182026_080936.xml | 0001397266-26-000004 | 12541 | ||||||
| 2026-09-18 | 3 | xslF345X06/form3-09182026_080923.xml | 0002153198-26-000002 | 16904 | ||||||
| 2026-09-18 | 3 | xslF345X06/form3-09182026_080916.xml | 0002153366-26-000004 | 16745 | ||||||
| 2026-09-18 | 3 | xslF345X06/form3-09182026_080910.xml | 0002153366-26-000003 | 11174 | ||||||
| 2026-09-18 | 3 | xslF345X06/form3-09182026_080956.xml | 0002153365-26-000002 | 19326 | ||||||
| 2026-09-18 | 3 | xslF345X06/form3-09182026_080950.xml | 0001282930-26-000012 | 16396 | ||||||
| 2026-09-18 | 3 | xslF345X06/form3-09182026_080900.xml | 0002153768-26-000002 | 11221 | ||||||
| 2026-09-18 | 3 | xslF345X06/form3-09182026_080919.xml | 0001817449-26-000007 | 13949 | ||||||
| 2026-09-18 | 3 | xslF345X06/form3-09182026_080911.xml | 0002153364-26-000002 | 19745 | ||||||
| 2026-09-18 | CERT | ETRA_8A_Cert_2088082.pdf | 0001354457-26-000887 | 001-43477 | 261388807 | 34 | 549057 | |||
| 2026-09-18 | 8-A12B | 8-A12B | 0001193125-26-394994 | 001-43477 | 261388402 | 34 | 14255 | |||
| 2026-09-17 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002994 | 333-298617 | 261388329 | 33 | 1787 | ||
| 2026-09-17 | S-1MEF | S-1MEF | 0001193125-26-394715 | 333-298997 | 261388085 | 33 | 191053 | 1 | 1 | |
| 2026-09-14 | S-1/A | S-1/A | 0001193125-26-389755 | 333-298617 | 261375721 | 33 | 8948257 | 1 | 1 | |
| 2026-08-28 | S-1 | S-1 | 0001193125-26-374259 | 333-298617 | 261339631 | 33 | 8684073 | 1 | 1 | |
| 2026-08-10 | DRS/A | filename1.htm | 0001193125-26-342694 | 377-09513 | 261259575 | 33 | 6263746 | |||
| 2026-06-26 | DRS | filename1.htm | 0001193125-26-285726 | 377-09513 | 261130561 | 33 | 5982009 | |||
| 2025-10-30 | D | xslFormDX01/primary_doc.xml | 06b | 0001231919-25-000372 | 021-562489 | 251431398 | 33 | 10300 |
One latest value per concept from companyfacts (114 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 62.87M | 2026-11-06 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 21,484.04 | 2026-09-18 | S-8 | 2026-09-21 | 0001193125-26-396741 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 21,484.04 | 2026-09-18 | S-8 | 2026-09-21 | 0001193125-26-396741 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 155.57M | 2026-09-18 | S-8 | 2026-09-21 | 0001193125-26-396741 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-09-18 | S-8 | 2026-09-21 | 0001193125-26-396741 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-09-17 | S-1MEF | 2026-09-17 | 0001193125-26-394715 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 8.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 858,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | AccruedBonusesCurrent | Accrued Bonuses, Current | USD | 2.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 8.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 13,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 638.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 4.49M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 7.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 8.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | Assets | Assets | USD | 410.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 406.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 17,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 4,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 152.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 73.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 73.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | USD | 79.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 79.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 152.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 256.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 402.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 256.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 223.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 900.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 62.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 62.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 6,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -72.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 311.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 40.00M | 2025-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 39.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 20.00M | 2025-03-07 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.08 | 2025-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | DebtInstrumentPeriodicPayment | Debt Instrument, Periodic Payment | USD | 41.40M | 2025-10-15 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss | Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss | USD | 900,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions | Security | 25 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | DeferredFinanceCostsNet | Debt Issuance Costs, Net | USD | 100,000 | 2025-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 5.50M | 2026-09-21 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 183,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -35.24 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -35.24 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 44.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | FinancialLiabilitiesFairValueDisclosure | Financial Liabilities Fair Value Disclosure | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 61,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | IncreaseDecreaseInAccountsPayableRelatedParties | Increase (Decrease) in Accounts Payable, Related Parties | USD | -83,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | 2.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 2.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -377,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 700,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | IncreaseDecreaseInOtherReceivables | Increase (Decrease) in Other Receivables | USD | 1.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -5.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 2.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | Liabilities | Liabilities | USD | 17.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 410.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 16.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 146.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 372.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -91.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -57.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -72.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -82.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 2.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 75.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -75.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 771,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 939,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 1.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 536,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 1.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | USD | -8,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | 26,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -2,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 804,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 1.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | PaidInKindInterest | Paid-in-Kind Interest | USD | 1.62M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 2.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 149.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | PaymentsToAcquireMachineryAndEquipment | Payments to Acquire Machinery and Equipment | USD | 27,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-21 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-21 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 3.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 3.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 1.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 325.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | ProceedsFromIssuanceOfCommercialPaper | Proceeds from Issuance of Commercial Paper | USD | 40.00M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 49.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 57.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 509,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 518,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 58.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -245.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | Revenues | Revenues | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 2.33M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 7.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 300,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 7.11 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 392.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 | |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 311.17M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 319.99M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 509,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 2.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 2.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-458476 |